1 outlets · filed 7 November 2026
US regulator investigates tumour risk in children given Novartis gene therapy
This story is from the archive. It was covered between
7 November 2026 and
7 November 2026, and nothing
below has been updated since. See what is happening now.
The US Food and Drug Administration said on Friday it was investigating a risk of neoplasia, or tumour formation including malignancy, associated with Novartis’ gene therapy Zolgensma. The Swiss drug maker earlier in the day disclosed two cases in which tumours in children showed evidence of bein
How it broke
7 Nov 03:35
South China Morning PostFirst
US regulator investigates tumour risk in children given Novartis gene therapy
South China Morning Post
In this story
Get the 5 stories every outlet is covering, every morning. Free.
One email a day. Unsubscribe in one click. We host no journalism and never sell your address.
More on Health
- Indonesia factory fire kills three, 36 missing 3 outlets
- Princess of Wales opens up about cancer 2 outlets
- Princess Kate reflects on healing in new documentary: "Cancer does change you" 2 outlets
- Violence breaks out in Mexico after capture of drug kingpin wanted by FBI 2 outlets
